0000898432-21-000772.txt : 20211209
0000898432-21-000772.hdr.sgml : 20211209
20211209214027
ACCESSION NUMBER: 0000898432-21-000772
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211207
FILED AS OF DATE: 20211209
DATE AS OF CHANGE: 20211209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HAWKINS JAMES B
CENTRAL INDEX KEY: 0000898243
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36534
FILM NUMBER: 211483504
MAIL ADDRESS:
STREET 1: C/O IRADIMED CORPORATION
STREET 2: 1025 WILLA SPRINGS DR.
CITY: WINTER SPRINGS
STATE: FL
ZIP: 32708
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IRADIMED CORP
CENTRAL INDEX KEY: 0001325618
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 731408526
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1025 WILLA SPRINGS DR.
CITY: WINTER SPRINGS
STATE: FL
ZIP: 32708
BUSINESS PHONE: 4076778022
MAIL ADDRESS:
STREET 1: 1025 WILLA SPRINGS DR.
CITY: WINTER SPRINGS
STATE: FL
ZIP: 32708
4
1
form4.xml
X0306
4
2021-12-07
0001325618
IRADIMED CORP
IRMD
0000898243
HAWKINS JAMES B
C/O IRADIMED CORPORATION
1025 WILLA SPRINGS DR.
WINTER SPRINGS
FL
32708
true
Common Stock
2021-12-07
4
A
0
18743
1.48
A
36011
D
Common Stock
2021-12-07
4
S
0
18743
47.073
D
17268
D
Common Stock
2021-12-07
4
M
0
4222
A
21490
D
Common Stock
2021-12-08
4
A
0
559
1.48
A
22049
D
Common Stock
2021-12-08
4
S
0
559
48.5
D
21490
D
Stock Options (Right to Buy)
1.48
2021-12-07
4
M
0
18743
0
D
2023-12-31
Common Stock
18743
10000
D
Restricted Stock Units
2021-12-07
4
M
0
4222
0
D
Common Stock
4222
2037
D
Restricted Stock Units
2021-12-07
4
A
0
2071
0
A
Common Stock
2071
2071
D
Stock Options (Right to Buy)
1.48
2021-12-08
4
M
0
559
0
D
2023-12-31
Common Stock
559
9441
D
This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date.
This transaction was executed in multiple trades at prices ranging from $46.30 to $48.54. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2020 and 2021. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
Restricted Stock Units convert to common stock on a one-for-one basis.
The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2022. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
/s/ James Hawkins
2021-12-09